Skip to content

#Health

1 result tagged #Health

A light blue pre-filled semaglutide injection pen with a Chinese-language Ozempic label lying on a grey surface
Lifestyle

Wegovy cut BMI in children as young as six in major trial, but it is not yet approved for them

A phase 3 trial published in the New England Journal of Medicine found that weekly semaglutide injections, the drug in Wegovy, lowered body mass index by 13.5% in children aged 6 to 11 with obesity, while BMI rose in children given a placebo. The drug is not approved for this age group in the US, and questions about long-term effects remain.

Kabeer Ahmad7 min read